NCT00751699View on ClinicalTrials.gov

Pharmacokinetics of Asacol 2.4 g/Day and Lialda 2.4 g/Day in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
Healthy
Interventions
DRUG

Asacol

Asacol tablets, 6 tablets per day at 7 am for 7 days

DRUG

Asacol

Asacol tablets, 400 mg, 2 tablets at 7 am, 3 pm, and 11 pm for 7 days

DRUG

Lialda

Lialda tablets 1.2 g, 2 tablets once a day at 7 am for 7 days

Trial Locations (1)

Unknown

Research Site, Miami

Sponsors

Lead Sponsor

Warner Chilcott
All Listed Sponsors
lead

Warner Chilcott

INDUSTRY

NCT00751699 - Pharmacokinetics of Asacol 2.4 g/Day and Lialda 2.4 g/Day in Healthy Volunteers | Biotech Hunter | Biotech Hunter